Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy

Yaeni KIM; Hye-Eun YOON; Byung-Ha CHUNG; Bum-Soon CHOI; Cheol-Whee PARK; Chul-Woo YANG; Yong-Soo KIM; Yu-Ah HONG; Suk-Young KIM; Yoon-Kyung CHANG; Hyeon-Seok HWANG.
The Korean Journal of Internal Medicine ; : 1091-1099, 2019.
Artículo en Inglés | WPRIM | ID: wpr-919142

Documentos relacionados

  1. Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy.
  2. Left Ventricular Mass Index in End-Stage Renal Disease Patients during Hemodialysis and Continuous Ambulatory Peritoneal Dialysis.
  3. Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group.
  4. Belatacept and Long-Term Outcomes in Kidney Transplantation.
  5. Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study.
  6. Long-term outcomes of patients with acute severe ulcerative colitis treated with cyclosporine rescue therapy.
  7. Assessing proximate intermediates between ambient temperature, hospital admissions, and mortality in hemodialysis patients.
  8. Fragmented QRS complex on a 12-lead electrocardiogram predicts cardiovascular and all-cause mortality in dialysis patients.
  9. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
  10. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.